Ubiquitin Conjugating Enzyme E2 Z (UBE2Z) is involved in the degradation of defective proteins and has been shown to be highly expressed in hepatocellular carcinoma compared to healthy controls and results in poor prognosis 68. This evidence concerns the gene UBE2Z and hepatocellular carcinoma.